Likewise, miR-181b-mediated PP2A repression in GBM cells contributes to increased GBM invasion through the deactivation of transcription factor-specific protein-1 (SP-1), a major target of the JNK pathway [63]. The gene discussed is PTPA; the disease is glioblastoma.